menu
    • menu

    Company profile for Eisai Inc

    NEW Drugs in Dev: 68
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and help to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., the company has a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a ...
    At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and help to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., the company has a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eisai IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Metro Blvd, Nutley, NJ 07110
    Telephone
    Telephone
    +1 2016921100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://us.eisai.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eisai/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/eisaius?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biogen, Eisai Face 3-Month Delay on SubQ Alzheimer's Therapy
    Biogen, Eisai Face 3-Month Delay on SubQ Alzheimer's Therapy

    08 May 2026

    // BIOSPACE

    https://www.biospace.com/fda/biogen-eisai-hit-with-3-month-delay-for-starting-subq-alzheimers-therapy

    BIOSPACE
    08 May 2026
    Share Share
    Merck’s Welireg Triplet Fails Phase 3 in first-line kidney Cancer
    Merck’s Welireg Triplet Fails Phase 3 in first-line kidney Cancer

    22 Apr 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-litespark-shocker-welireg-triplet-misses-mark-first-line-kidney-cancer

    FIERCE PHARMA
    22 Apr 2026
    Share Share
    Tortugas Comes Out Of Shell With $106M, 4 Ph. 2-Stage Neuro Meds
    Tortugas Comes Out Of Shell With $106M, 4 Ph. 2-Stage Neuro Meds

    21 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tortugas-comes-out-its-shell-106m-fund-4-phase-2-stage-neuro-drugs

    FIERCE BIOTECH
    21 Apr 2026
    Share Share
    Merck, Eisai Update on LITESPARK-012 Phase 3 RCC Trial
    Merck, Eisai Update on LITESPARK-012 Phase 3 RCC Trial

    21 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260421205834/en/Merck-and-Eisai-Provide-Update-on-Phase-3-LITESPARK-012-Trial-Evaluating-First-Line-Combination-Treatments-for-Certain-Patients-With-Advanced-Renal-Cell-Carcinoma-RCC

    BUSINESSWIRE
    21 Apr 2026
    Share Share
    Eisai To Present Real-World Lecanemab Data For Early Alzheimer
    Eisai To Present Real-World Lecanemab Data For Early Alzheimer

    09 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-to-present-the-latest-data-on-real-world-treatment-with-lecanemab-and-supporting-a-standardized-framework-for-treating-early-alzheimers-disease-at-the-78th-american-academy-of-neurologys-annual-meeting-302736277.html

    PR NEWSWIRE
    09 Apr 2026
    Share Share
    Eisai, Nuvation Bio Seek Ema Approval For Taletrectinib In Cancer
    Eisai, Nuvation Bio Seek Ema Approval For Taletrectinib In Cancer

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-and-nuvation-bio-announce-marketing-authorisation-application-for-taletrectinib-for-the-treatment-of-advanced-ros1-positive-non-small-cell-lung-cancer-validated-by-the-european-medicines-agency-302726651.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Eisai Inc and get a quotation

    Eisai Inc is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find MOH040 bulk with DMF offered by Eisai Inc

    Find INTERLEUKIN-2 DIPHTHERIA TOXIN FUSION PROTEIN (DAB 389 IL-2) bulk offered by Eisai Inc

    Find Eperisone Hydrochloride bulk offered by Eisai Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search